Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CVS Health Corp filings on SEC EDGAR ↗
CVS Health EVP and Group President Prem S. Shah Buys $2M of Stock
Prem S. Shah, EVP and Group President, bought 23,855 shares of CVS Health Corp at $83.89 a share, worth $2M in total on Nov 6, 2026. Shares held after the trade: 88,516 (+36.9%).
CVS Health reported total revenues of $108.4 billion for the third quarter of 2026, up from $102.9 billion in the prior year. The company returned to profitability with a net income of $2.17 billion compared to a net loss of $3.98 billion in Q3 2025, which had been impacted by a $5.7 billion goodwill impairment charge.
CVS Health announced its intention to separate into two independent, publicly traded companies: a healthcare solutions company (including Aetna and Caremark) and a national retail pharmacy company (CVS Pharmacy). The transaction is expected to be completed in the first half of 2028 and is intended to be tax-free for the company and its shareholders.
CVS Health reported third-quarter 2026 total revenues of $108.4 billion, a 5.4% year-over-year increase, and GAAP diluted EPS of $1.68. The company raised its full-year 2026 Adjusted EPS guidance to at least $8.20, citing strong performance across all operating segments and execution of its margin recovery plan in the Health Care Benefits segment.
Term
Q3 2026
“Our colleagues build trust every day through delivering quality health care rooted in our purpose - to simplify health care one person, one family and one community at a time. Through their continued dedication, each of our businesses delivered another quarter of strong results. We continue to advance our strategy by improving the consumer experience, lowering health care costs, and connecting care for the people we serve.”